Neurobiology   [<<] [1] [2] [3] [4] [5] [>>] 1/24      


[4/20/2017] Lilly to Present Data for Galcanezumab for the Prevention of Migr...

[4/11/2017] Neurocrine Announces FDA Approval of INGREZZA TM (valbenazine) Ca...

[3/27/2017] Neurotrope, Inc. Announces Approval for Listing on the NASDAQ Cap...

[3/22/2017] BrainStorm CEO to Present at the Sachs Associates 2nd Annual Neur...

[3/15/2017] FundRx Announces Investment in NeuroOne Inc.

[3/2/2017] ProMIS Neurosciences Announces Appointment of Anthony Giovinazzo ...

[2/22/2017] ProMIS Neurosciences issues white paper entitled “Results from re...

[2/22/2017] Dr. Daniel Spyker, Former FDA acting Deputy Division Director of ...

[2/8/2017] Neurotrope Bioscience to Present at the 19th Annual BIO CEO &...

[2/3/2017] Neuromorphic Chip Market: U.S. Neuromorphic Chip Market Projected...

[1/27/2017] Neurotrope Bioscience to Present at the Noble Financial Capital M...

[1/26/2017] Salivary Diagnostics from Salimetrics Support daacro, a German Co...

[1/23/2017] AxioMed Continues International Growth with Workshop and Presenta...

[1/17/2017] Researchers Publish Preclinical Data on Reversing Peripheral Neur...

[1/6/2017] ProMIS Neurosciences Declares PMN 310 its First Lead Product for ...

[12/28/2016] ‘Latest spoke in the wheel’ drives brain-mapping advances, notes ...

[12/22/2016] Neurocrine Biosciences Announces Chief Financial Officer Timothy ...

[12/8/2016] Optical Probes Overcome Light-Scattering Issue in Deep-Brain Imag...

[12/6/2016] Creative Medical Technology Holdings Recruits Internationally Ren...

[12/6/2016] ProMIS Neurosciences Announces Novel Alzheimer’s Disease Therapeu...


Neurobiology   [<<] [1] [2] [3] [4] [5] [>>] 1/24      
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):
(Date:4/24/2017)... ... April 24, 2017 , ... In 2017, up to ... approximately 25,000 of them will be malignant.(1) As research into precision medicine continues, ... healthcare model in the diagnosis and treatment of brain tumors. Healthcare facilities that ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively ... it is not known to have significant interactions with antiretroviral therapy (ART). ... cholesterol levels and dampen inflammation in the bloodstream. , While lowering cholesterol and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often ... it difficult for lab operators and management to assess these processes with a ... wasteful or unnecessary actions. , Created with the help of both internal ...
(Date:4/24/2017)... ... , ... “Reflections of God’s Work”: an enlightening collection of life lessons leading ... of published author, Jerri Broglin, a survivor of great loss who gained insight on ... eye-opener for those searching for answers, as we are finding the answers that are ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and ... Foundation will present its annual Global Symposium at the Fontainebleau Hotel located in ...
Breaking Medicine News(10 mins):